← Leaderboards
Shiyi Wang
Yale University
$2,095,372
Attributed
$3,919,325
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $771.2K · FY2015–25$1M$750K$500K$250K$0
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,165,787 · 1
AHRQ$753,538 · 1
By mechanism
U01$3,165,787 · 1
K01$753,538 · 1
Top collaborators
- Su-Hsin Chang6 shared
- Graham A Colditz3 shared
Most similar at Yale University
Same institution · by research overlap
- Theodore R Holford$8,685,368
- Ronald Scott Braithwaite$34,131,274
- Suchitra Krishnan-Sarin$33,936,702
- Jody L. Sindelar$5,980,478
- Stephanie S O'Malley$41,813,757
Others in their field
Top investigators on “Diagnosis”
- David Heimbrook · Leidos Biomedical Research, Inc.$590,717,255
- Bambra Strokes · Ppd Development Lp$526,656,217
- Leonard Freedman · Leidos Biomedical Research, Inc.$337,858,596
- Richard K. Wilson · Washington University$297,645,172
- Sharon A Nachman · Johns Hopkins University$212,395,175
- Carol Nesel · Westat$188,148,170
Research focus
DiagnosisHematologic NeoplasmsPreventionWashingtonCost-Effectiveness EvaluationComparativeIncubatorsMultiple MyelomaCancer Intervention And Surveillance Modeling NetworkUniversitiesProgramsCancer SiteCostInnovationEvidence BaseClinical TrialsClinical PracticeDisparity ReductionCessation Of LifeEvaluationFlexibilityHealth DisparityAdultDisease Natural History
Grant awards (11)
Comparative modeling of multiple myeloma across myeloma continuum: prevention, treatment, and health drivers$624,497
U01 · FY2025 · CA
Comparative modeling of multiple myeloma across myeloma control continuuum: prevention, treatment, and disparity reduction$462,628
U01 · FY2024 · CA
Comparative modeling of multiple myeloma across myeloma control continuuum: prevention, treatment, and disparity reduction$632,304
U01 · FY2023 · CA
Comparative modeling of multiple myeloma across myeloma control continuum: prevention, treatment, and disparity reduction$138,880
U01 · FY2023 · CA
Comparative modeling of multiple myeloma across myeloma control continuuum: prevention, treatment, and disparity reduction$643,761
U01 · FY2022 · CA
Comparative modeling of multiple myeloma across myeloma control continuuum: prevention, treatment, and disparity reduction$663,717
U01 · FY2021 · CA
Development and Evaluation of a Decision Analysis Based Decision Aid$153,817
K01 · FY2019 · HS · contact PI
Development and Evaluation of a Decision Analysis Based Decision Aid$153,413
K01 · FY2018 · HS · contact PI
Development and Evaluation of a Decision Analysis Based Decision Aid$152,442
K01 · FY2017 · HS · contact PI
Development and Evaluation of a Decision Analysis Based Decision Aid$149,021
K01 · FY2016 · HS · contact PI
Development and Evaluation of a Decision Analysis Based Decision Aid$144,845
K01 · FY2015 · HS · contact PI